Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Harry Dolstra benoemd tot hoogleraar Translationele Immunohematologie
jun 2023 | Immuuntherapie, Leukemie, Lymfoom